Close
(0) items
You have no items in your shopping cart.
All Categories
    Filters
    Preferences
    Search

    Personalized Drug Screening for Functional Tumor Profiling

    €19.84
    This Element discusses personalized drug screening as a novel patient stratification strategy for the determination of individualized treatment choices in oncology.
    ISBN: 9781009016933
    AuthorEl-Khoury, Victoria
    SubAuthor1Michel, Tatiana
    SubAuthor2Kim, Hichul
    SubAuthor3Kwon, Yong-Jun
    Pub Date07/07/2022
    BindingPaperback
    Pages75
    AvailabilityCurrently out of stock. If available, delivery is usually 5-10 working days.
    EditionNew Ed
    Availability: Out of Stock

    Despite considerable advances in our understanding of the biology that underlies tumor development and progression of cancer and the rapidly evolving field of personalized medicine, cancer is still one of the deadliest diseases. Many cancer patients have benefited from the survival improvements observed with targeted therapies but only a small subset of patients receiving targeted drugs experience an objective response. Because cancer is a complex and heterogeneous disease, the search for effective cancer treatments will need to address not only patient-specific molecular defects but also aspects of the tumor microenvironment. The functional tumor profiling directly measures the cellular phenotype, in particular tumor growth, in response to drugs using patient-derived tumor models and might be the next step toward precision oncology. In this Element, the authors discuss the personalized drug screening as a novel patient stratification strategy for the determination of individualized treatment choices in oncology.

    Write your own review
    • Only registered users can write reviews
    *
    *
    • Bad
    • Excellent
    *
    *
    *

    Despite considerable advances in our understanding of the biology that underlies tumor development and progression of cancer and the rapidly evolving field of personalized medicine, cancer is still one of the deadliest diseases. Many cancer patients have benefited from the survival improvements observed with targeted therapies but only a small subset of patients receiving targeted drugs experience an objective response. Because cancer is a complex and heterogeneous disease, the search for effective cancer treatments will need to address not only patient-specific molecular defects but also aspects of the tumor microenvironment. The functional tumor profiling directly measures the cellular phenotype, in particular tumor growth, in response to drugs using patient-derived tumor models and might be the next step toward precision oncology. In this Element, the authors discuss the personalized drug screening as a novel patient stratification strategy for the determination of individualized treatment choices in oncology.